Related Experiment Videos
Daytime somnolence: therapeutic approaches
C Guilleminault1, R Stoohs, A Clerk
1Stanford University Sleep Disorders Clinic and Research Center, Palo Alto, CA 94304.
Neurophysiologie Clinique = Clinical Neurophysiology
|January 1, 1993
Summary
Excessive daytime somnolence (EDS) affects 4% of people and requires accurate diagnosis. Sleep-disordered breathing is a key cause, while stimulant medications can help other cases.
Area of Science:
- Neurology
- Sleep Medicine
Background:
- Excessive daytime somnolence (EDS) is a significant neurological issue affecting approximately 4% of the global population.
- Accurate etiological diagnosis is crucial for effective EDS management.
- Sleep-disordered breathing (SDB) is a primary contributor to EDS.
Purpose of the Study:
- To highlight the importance of etiological dissection in treating excessive daytime somnolence.
- To identify major causes and treatment strategies for EDS.
Main Methods:
- Review of etiological factors contributing to excessive daytime somnolence.
- Analysis of the role of sleep-disordered breathing in EDS.
- Evaluation of stimulant medication efficacy in managing EDS.
Main Results:
- Sleep-disordered breathing is identified as a major cause of excessive daytime somnolence.
- Stimulant medication is noted as a beneficial treatment option for other instances of EDS.
Conclusions:
- Accurate etiological diagnosis is paramount for the successful treatment of excessive daytime somnolence.
- Addressing sleep-disordered breathing is essential for managing a significant portion of EDS cases.
- Pharmacological interventions, such as stimulant medication, offer therapeutic benefits for EDS.